Literature DB >> 24973036

Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.

Sevil Cankaya1, Berfu Demir2, Sezin Erturk Aksakal3, Berna Dilbaz3, Canan Demirtas4, Umit Goktolga5.   

Abstract

OBJECTIVE: To assess the rate of insulin resistance (IR) and the relationship between IR and high molecular weight (HMW) adiponectin in normal weight adolescents with polycystic ovary syndrome (PCOS) and a maternal history of PCOS.
DESIGN: Case-controlled study.
SETTING: Adolescent clinic of a teaching and research hospital. PATIENT(S): Forty normal weight adolescents with PCOS and a maternal history of PCOS and 40 normo-ovulatory age- and body mass index (BMI)-matched controls. INTERVENTION(S): A 75-g oral glucose tolerance test (OGTT) was performed for each participant. MAIN OUTCOME MEASURE(S): Homeostasis model assessment of IR and HMW adiponectin. RESULT(S): There were no statistically significant differences between the PCOS and control groups in terms of fasting glucose, fasting insulin, and lipid parameters. Although total and free T were significantly higher, HMW adiponectin levels were significantly lower in the PCOS group compared with the control group. When the PCOS group was compared according to the IR, the HMW adiponectin level was significantly lower in the adolescents with PCOS and IR. The adolescents with PCOS and biochemical hyperandrogenemia had significantly lower HMW adiponectin levels and significantly higher homeostasis model assessment of IR score compared with the adolescents with PCOS and normoandrogenemia. CONCLUSION(S): The adolescents with PCOS had a significantly increased rate of IR without clinical findings of metabolic disorders or obesity. The HMW adiponectin levels were negatively correlated with IR.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  High molecular weight adiponectin; insulin resistance; polycystic ovary syndrome

Mesh:

Substances:

Year:  2014        PMID: 24973036     DOI: 10.1016/j.fertnstert.2014.05.032

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?

Authors:  Giovanni Targher; Maurizio Rossini; Amedeo Lonardo
Journal:  Endocrine       Date:  2015-05-30       Impact factor: 3.633

2.  Inhibition of sestrin 1 alleviates polycystic ovary syndrome by decreasing autophagy.

Authors:  Xiaoyuan Xu; Xinli Song; Xiaohua Xu; Yanluan Zheng; Lan Xu; Ling Shen
Journal:  Aging (Albany NY)       Date:  2021-04-22       Impact factor: 5.682

3.  Association of fetuin A, adiponectin, interleukin 10 and total antioxidant capacity with IVF outcomes.

Authors:  Mustafa Yen; Orkide Donma; Ferdag Yildizfer; Ozlem Ekmekci; Z Asli Karatas Kul; A Esat Imal; Zafer Keser; Emin Cagil; Murat Mengi; Hakan Ekmekci; Sezai Sahmay; Metin Donma
Journal:  Iran J Reprod Med       Date:  2014-11

4.  The Influence of a KDT501, a Novel Isohumulone, on Adipocyte Function in Humans.

Authors:  Brian S Finlin; Beibei Zhu; Bernard P Kok; Cristina Godio; Philip M Westgate; Neile Grayson; Robert Sims; Jeffrey S Bland; Enrique Saez; Philip A Kern
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-29       Impact factor: 5.555

5.  Association of vitamin D receptor gene variants with polycystic ovary syndrome: A case control study.

Authors:  Touraj Mahmoudi; Keivan Majidzadeh-A; Hamid Farahani; Mojgan Mirakhorli; Reza Dabiri; Hossein Nobakht; Asadollah Asadi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2015-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.